Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 29 12 2022
accepted: 04 04 2023
medline: 9 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: epublish

Résumé

Currently, the differentiated thyroid cancer (DTC) management is shifted toward a tailored approach based on the estimated risks of recurrence and disease-specific mortality. While the current recommendations on the management of metastatic and progressive DTC are clear and unambiguous, the management of slowly progressive or indeterminate disease varies according to different centers and different physicians. In this context, active surveillance (AS) becomes the main tool for clinicians, allowing them to plan a personalized therapeutic strategy, based on the risk of an unfavorable prognosis, and to avoid unnecessary treatment. This review analyzes the main possible scenarios in treated DTC patients who could take advantage of AS.

Identifiants

pubmed: 37152950
doi: 10.3389/fendo.2023.1133958
pmc: PMC10157216
doi:

Substances chimiques

Iodine Radioisotopes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133958

Informations de copyright

Copyright © 2023 Campopiano, Ghirri, Prete, Lorusso, Puleo, Cappagli, Agate, Bottici, Brogioni, Gambale, Minaldi, Matrone, Elisei and Molinaro.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur Arch Otorhinolaryngol. 2018 Nov;275(11):2851-2859
pubmed: 30229453
Thyroid. 2010 Dec;20(12):1341-9
pubmed: 21034228
Thyroid. 2012 Aug;22(8):778-83
pubmed: 22780333
J Clin Endocrinol Metab. 2005 Oct;90(10):5723-9
pubmed: 16030160
Clin Endocrinol (Oxf). 2012 Jul;77(1):132-8
pubmed: 22248037
J Thyroid Res. 2013;2013:398194
pubmed: 24455413
Thyroid. 2006 Dec;16(12):1229-42
pubmed: 17199433
Thyroid. 2018 Jul;28(7):871-879
pubmed: 29860933
Cancer. 1998 Dec 15;83(12):2638-48
pubmed: 9874472
Clin Oncol (R Coll Radiol). 2019 Feb;31(2):e11-e20
pubmed: 30454940
J Clin Oncol. 2017 Aug 10;35(23):2692-2699
pubmed: 28613956
Thyroid. 2017 Apr;27(4):524-530
pubmed: 27869547
J Clin Endocrinol Metab. 2003 Mar;88(3):1107-11
pubmed: 12629092
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32453405
J Endocrinol Invest. 2005 Jun;28(6):540-6
pubmed: 16117196
Thyroid. 2012 Nov;22(11):1144-52
pubmed: 23083442
Endocrine. 2016 Nov;54(2):467-475
pubmed: 26668060
Thyroid. 2016 Apr;26(4):518-24
pubmed: 26872102
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):346-51
pubmed: 12965943
Ann Surg Oncol. 2019 Jun;26(6):1737-1743
pubmed: 30820785
Hell J Nucl Med. 2019 May-Aug;22(2):123-130
pubmed: 31273354
Clin Endocrinol (Oxf). 2011 Jul;75(1):112-9
pubmed: 21521273
Thyroid. 2011 Dec;21(12):1317-22
pubmed: 22136267
J Clin Endocrinol Metab. 2003 Aug;88(8):3668-73
pubmed: 12915653
J Clin Endocrinol Metab. 2016 Aug;101(8):3036-44
pubmed: 27186860
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22
pubmed: 24557566
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020
pubmed: 28859191
J Endocrinol Invest. 2019 Oct;42(10):1223-1230
pubmed: 30963467
Surgery. 2016 Mar;159(3):755-62
pubmed: 26435440
Thyroid. 2018 Dec;28(12):1587-1594
pubmed: 30226447
Clin Endocrinol (Oxf). 2019 Apr;90(4):617-622
pubmed: 30706513
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31652318
J Clin Endocrinol Metab. 2013 May;98(5):E829-36
pubmed: 23533233
J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53
pubmed: 22679061
Endocr Pract. 2017 Oct;23(10):1193-1200
pubmed: 28704099
Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):33-7
pubmed: 22249626
Thyroid. 2018 Jan;28(1):72-78
pubmed: 29048237
Clin Transl Oncol. 2018 Jun;20(6):740-744
pubmed: 29071517
Eur Thyroid J. 2019 Oct;8(5):227-245
pubmed: 31768334
J Clin Endocrinol Metab. 2017 Mar 1;102(3):893-902
pubmed: 27929713
J Clin Endocrinol Metab. 2001 Sep;86(9):4092-7
pubmed: 11549631
J Endocrinol Invest. 2018 Jul;41(7):849-876
pubmed: 29729004
J Clin Endocrinol Metab. 2012 Aug;97(8):2706-13
pubmed: 22639292
Am J Med. 1994 Nov;97(5):418-28
pubmed: 7977430
J Clin Endocrinol Metab. 2010 May;95(5):2187-94
pubmed: 20332244
Thyroid. 2009 Nov;19(11):1167-214
pubmed: 19860577
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
pubmed: 16684830
Lancet. 2014 Jul 26;384(9940):319-28
pubmed: 24768112
Endocr Rev. 2013 Jun;34(3):439-55
pubmed: 23575762
Ann Surg Oncol. 2012 Sep;19(9):2951-7
pubmed: 22526913
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
J Clin Endocrinol Metab. 2007 Sep;92(9):3590-4
pubmed: 17609301
J Clin Endocrinol Metab. 2011 Jul;96(7):2049-56
pubmed: 21508143
Eur Thyroid J. 2013 Sep;2(3):147-59
pubmed: 24847448
Thyroid. 2011 Aug;21(8):845-53
pubmed: 21809914
Endocrine. 2020 Feb;67(2):387-396
pubmed: 31650394
J Clin Endocrinol Metab. 1992 Jun;74(6):1401-4
pubmed: 1592886
J Clin Endocrinol Metab. 2008 Dec;93(12):4683-9
pubmed: 18812478
PLoS One. 2019 Jun 25;14(6):e0218416
pubmed: 31237886
J Clin Endocrinol Metab. 2016 Jul;101(7):2692-700
pubmed: 27023446
J Clin Endocrinol Metab. 2011 Jun;96(6):1703-9
pubmed: 21450986
JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):947-948
pubmed: 30178005
J Clin Endocrinol Metab. 2006 Jan;91(1):60-3
pubmed: 16219716
Minerva Chir. 2010 Feb;65(1):71-82
pubmed: 20212419
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Thyroid. 2014 Jan;24(1):27-34
pubmed: 24001104
Thyroid. 2016 Dec;26(12):1706-1711
pubmed: 27616725
J Clin Endocrinol Metab. 2018 Feb 1;103(2):446-451
pubmed: 29211863
Cancer. 2017 Aug 1;123(15):2955-2964
pubmed: 28369717
J Clin Endocrinol Metab. 2017 Mar 01;102(3):1020-1031
pubmed: 28359102
Laryngoscope. 2008 May;118(5):768-75
pubmed: 18197134
World J Surg. 2013 Dec;37(12):2853-9
pubmed: 24045964
Clin Endocrinol (Oxf). 2002 Aug;57(2):215-21
pubmed: 12153600
Endocr J. 2013;60(7):871-6
pubmed: 23585494
Thyroid. 2011 Jul;21(7):707-16
pubmed: 21649472

Auteurs

Maria Cristina Campopiano (MC)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Arianna Ghirri (A)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Alessandro Prete (A)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Loredana Lorusso (L)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Luciana Puleo (L)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Virginia Cappagli (V)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Laura Agate (L)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Valeria Bottici (V)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Sandra Brogioni (S)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Carla Gambale (C)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Elisa Minaldi (E)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Antonio Matrone (A)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Rossella Elisei (R)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Eleonora Molinaro (E)

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH